Assignee
STEMLINE THERAPEUTICS INC
US·10 granted patents·16 pending applications·9 citations·filing 2013–2024
Top patents by PatentIndex Score
26 records- 0193US2025154269A1IL3Ra Antibody Conjugates and Uses ThereofSTEMLINE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0289US9518119B2IL3Rα antibody conjugates and uses thereofSTEMLINE THERAPEUTICS INC·Filed 2015·Granted Dec 13, 2016·5 cites·37 claims
- 0383US9873743B2IL3Rα antibody conjugates and uses thereofSTEMLINE THERAPEUTICS INC·Filed 2016·Granted Jan 23, 2018·2 cites·37 claims
- 0481US12357678B2Cancer stem cell targeted cancer vaccinesSTEMLINE THERAPEUTICS INC·Filed 2023·Granted Jul 15, 2025·0 cites·14 claims
- 0581US10485858B2Cancer stem cell targeted cancer vaccinesSTEMLINE THERAPEUTICS INC·Filed 2013·Granted Nov 26, 2019·2 cites·19 claims
- 0678US12187802B2IL3Ralpha antibodies and uses thereofSTEMLINE THERAPEUTICS INC·Filed 2020·Granted Jan 7, 2025·0 cites·10 claims
- 0778US10906979B2IL3Ralpha antibody conjugates and uses thereofSTEMLINE THERAPEUTICS INC·Filed 2019·Granted Feb 2, 2021·0 cites·37 claims
- 0878US2024342259A1Cancer Stem Cell-Targeted Cancer TherapySTEMLINE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0977US2023324391A1Monitoring Cancer Stem CellsSTEMLINE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1075US2023374152A1Methods for Treating and Monitoring the Status of CancerSTEMLINE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1173US2021388354A1Methods of Manipulating the Fate of CellsSTEMLINE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1272US11672847B2Cancer stem cell targeted cancer vaccinesSTEMLINE THERAPEUTICS INC·Filed 2019·Granted Jun 13, 2023·0 cites·20 claims
- 1371US2020330566A1Cancer Stem Cell-Targeted Cancer TherapySTEMLINE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1468US10316098B2IL3Rα antibody conjugates and uses thereofSTEMLINE THERAPEUTICS INC·Filed 2017·Granted Jun 11, 2019·0 cites·37 claims
- 1567US12357700B2Combination therapy method of treating myeloproliferative neoplasms with a diphtheria toxin-human interleukin-3 conjugate in combination with other agentsSTEMLINE THERAPEUTICS INC·Filed 2019·Granted Jul 15, 2025·0 cites·19 claims
- 1666US12171800B2Lyophilized formulationSTEMLINE THERAPEUTICS INC·Filed 2023·Granted Dec 24, 2024·0 cites·28 claims
- 1765US2018364237A1Monitoring Cancer Stem CellsSTEMLINE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1864US2025057915A1Improved Lyophilized FormulationSTEMLINE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1960US2015224083A1Cancer Therapy With Cantharidin And Cantharidin AnalogsSTEMLINE THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2059US2017146536A1Monitoring cancer stem cellsSTEMLINE THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2154US2023158005A1Substituted Azole Dione Compounds with Antiviral ActivitySTEMLINE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2252US2015079135A1Methods for treating and monitoring the status of cancerSTEMLINE THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 2352US2019031772A1Methods for treating and monitoring the status of cancerSTEMLINE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2452US2021361744A1Methods of Treating an Autoimmune Disease with a Human Interleukin-3 (IL-3)-Diphtheria Toxin Conjugate (DT-IL3)STEMLINE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2548US2025064809A1Inhibitors of Mutant RET Kinases for use in Treating CancerSTEMLINE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2637US2022202824A1Methods for Treating Centronuclear MyopathySTEMLINE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when STEMLINE THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →